BRIEF published on 04/02/2024 at 17:05, 1 year 8 months ago Bux Pain Management Launches SynchroMed III Pain Pump FDA Approval Chronic Pain Treatment SynchroMed III Pump Pain Management Technology Opioid Alternative
BRIEF published on 04/02/2024 at 17:05, 1 year 8 months ago Bux Pain Management lance la pompe anti-douleur SynchroMed III Traitement De La Douleur Chronique Approbation De La FDA Pompe SynchroMed III Technologie De Gestion De La Douleur Alternative Aux Opioïdes
PRESS RELEASE published on 04/02/2024 at 17:00, 1 year 8 months ago Bux Pain Management Introduces Innovative SynchroMed III Pain Pump to Its Practice Bux Pain Management implements SynchroMed III intrathecal drug delivery system, revolutionizing pain management therapy with enhanced safety and efficiency Innovative Technology Pain Management Chronic Pain Bux Pain Management SynchroMed III
PRESS RELEASE published on 12/12/2023 at 16:00, 2 years ago Bux Pain Management Welcomes Mandi Tomazic, Board-Certified Family Nurse Practitioner, to Its Esteemed Team
Published on 12/18/2025 at 00:55, 2 hours 59 minutes ago Molten Metals Corp. Announces Flow-Through Financing
Published on 12/18/2025 at 00:00, 3 hours 54 minutes ago Right Season Investments Announces Name Change to FutureGen Industries Corp.
Published on 12/17/2025 at 23:15, 4 hours 39 minutes ago Northern Superior Announces the Ratio for the Distribution of the Common Shares in the Capital of ONGold Resources Ltd.
Published on 12/17/2025 at 15:00, 12 hours 54 minutes ago BlackBerry Unveils Ground-Up Modernization of BlackBerry AtHoc Mobile Experience to Enable More Intelligent Operations
Published on 12/17/2025 at 14:00, 13 hours 54 minutes ago UniDoc Completes H3 Health Cube Installation in Italy
Published on 12/18/2025 at 01:10, 2 hours 44 minutes ago Samsung To Unveil New AI-Connected Living Lineup at CES 2026
Published on 12/18/2025 at 00:50, 3 hours 4 minutes ago Historic production of graphene enhanced cement successfully completed
Published on 12/17/2025 at 22:05, 5 hours 49 minutes ago Abivax annonce l’acceptation de 22 abstracts sur obefazimod dans les MICI à l’ECCO 2026, dont une présentation orale sur des résultats précliniques antifibrotiques
Published on 12/17/2025 at 22:05, 5 hours 49 minutes ago Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings
Published on 12/17/2025 at 21:22, 6 hours 32 minutes ago EQS-Adhoc: DATAGROUP SE: DATAGROUP SE Management Board plans dividend of EUR 0.04 per share
Published on 12/17/2025 at 20:39, 7 hours 15 minutes ago Aeroports de Paris SA | 2026 Airport charges in Paris
Published on 12/17/2025 at 20:39, 7 hours 15 minutes ago Aeroports de Paris SA | Tarifs des redevances aeroportuaires 2026 à Paris
Published on 12/17/2025 at 19:30, 8 hours 24 minutes ago Evolution de la composition du Conseil d’Administration
Published on 12/17/2025 at 18:00, 9 hours 54 minutes ago Outstanding Shares and Voting Rights Statement at 30 November 2025
